U.S. Physical Therapy acquires 12-clinic practice, adds new state; $12M revenue, 112k visits
U.S. Physical Therapy announced the acquisition of a 12-clinic practice, acquiring a 67% equity stake. This acquisition is expected to generate approximately $12 million in annual revenue and 112,000 annual visits. The deal also expands the company's presence to a new, 45th state, with current owners retaining a 33% equity interest.
U.S. Physical Therapy (USPH) adds 12-clinic deal, expanding into 45th state
U.S. Physical Therapy, Inc. (USPH) has acquired a twelve-clinic physical therapy practice, taking a 67% equity interest and expanding its presence into its 45th state. This acquisition, effective July 1, 2026, adds approximately 112,000 annual patient visits and $12 million in annual revenue to USPH's operations. The deal strengthens USPH's national network, which now comprises 795 outpatient physical therapy clinics.
10 Best Medical Care Facilities Stocks to Buy According to Analysts
This article identifies U.S. Physical Therapy, Inc. (NYSE:USPH) as one of the top medical care facilities stocks to buy, according to analysts, citing an average upside of 29.5%. The company recently expanded its footprint through the acquisition of a twelve-clinic physical therapy practice, generating substantial annual visits and revenue. This strategic expansion and consistent growth tied to outpatient capacity contribute to its appeal among analysts.
U.S. Physical Therapy Announces the Acquisition of a Twelve-Clinic Physical Therapy Practice
U.S. Physical Therapy, Inc. (USPH) acquired a twelve-clinic physical therapy practice, effective July 1, 2026, gaining a 67% equity interest. This expansion into a new state increases USPH's footprint to 45 states, adding 112,000 annual visits and $12 million in revenue. The acquisition reinforces USPH's commitment to providing high-quality physical therapy services and leveraging national resources for growth.
US Physical Therapy Buys Majority Stake in 12-Clinic Physical Therapy Practice
US Physical Therapy, Inc. has acquired a majority stake in a 12-clinic physical therapy practice, adding to its growing portfolio. This acquisition expands the company's presence and continues its strategy of acquiring established physical therapy operations. Specific financial terms of the deal were not disclosed.
U.S. Physical Therapy (USPH) Acquires Majority Stake in New Clin
U.S. Physical Therapy Inc (USPH) has acquired a 67% stake in a physical therapy practice operating twelve clinics, projected to add 112,000 patient visits and $12 million in annual revenue. The company currently has a high P/E ratio of 142.62, signaling a premium valuation, and a GF Score of 77/100, indicating strong growth and profitability but average financial strength. Insider activity shows one recent share purchase but more sell transactions over the past year.
US Physical Therapy buys majority stake in a physical therapy practice
This article reports that US Physical Therapy has acquired a majority stake in a physical therapy practice. The acquisition is expected to enhance US Physical Therapy's footprint in the healthcare sector by expanding its service offerings and geographical reach.
U.S. Physical Therapy Acquires 12-Clinic Practice, Expands Footprint to 45 States
U.S. Physical Therapy Inc. has expanded its national outpatient rehabilitation platform by acquiring a majority interest in a 12-clinic physical therapy practice, extending its operations into a new state and increasing its presence to 45 states. This acquisition, which became effective July 1, 2026, involves U.S. Physical Therapy acquiring a 67% equity interest and is expected to add approximately $12 million in annual revenue from 112,000 patient visits. The strategy aligns with the company's goal of combining local ownership and clinical expertise with national resources and operational support to drive continued growth.
U.S. Physical Therapy acquires 12-clinic practice in new state
U.S. Physical Therapy, Inc. (NYSE:USPH) has expanded its operations by acquiring a 12-clinic physical therapy practice, taking a 67% equity interest. This acquisition, which generates $12 million in annual revenue, marks the company's entry into a new state, increasing its footprint to 45 states. Despite recent financial setbacks in Q1 2026, analysts remain positive, reiterating a "Market Outperform" rating with a $98.00 price target.
U.S. Physical Therapy Announces the Acquisition of a Twelve-Clinic Physical Therapy Practice
U.S. Physical Therapy, Inc. (USPH) has acquired a twelve-clinic physical therapy practice, effective July 1, 2026. This acquisition gives USPH a 67% equity interest in the practice, which generates approximately 112,000 annual visits and $12 million in annual revenue, expanding USPH's presence to 45 states. The move underscores USPH's commitment to growth and providing high-quality physical therapy services.
Is U.S. Physical Therapy’s (USPH) Hospital Alliance Push Quietly Redefining Its Earnings Engine?
U.S. Physical Therapy (USPH) is increasingly relying on hospital alliances as a key earnings driver, exemplified by its expanded Metro-NYU Langone partnership. While these partnerships and a growing pipeline of collaborations are expected to enhance revenue mix and scale, the company still faces challenges from rising labor costs and reimbursement pressures. USPH's investment narrative projects significant revenue and earnings growth by 2029, with a fair value estimate suggesting substantial upside.
Citizens reiterates U.S. Physical Therapy stock rating on partnership growth By Investing.com
Citizens has reaffirmed its "Market Outperform" rating and $98.00 price target for U
The Technical Signals Behind (USPH) That Institutions Follow
This article from Stock Traders Daily analyzes U.s. Physical Therapy Inc. (USPH) using AI models to identify technical signals and institutional trading strategies. It highlights a strong near-to-mid-term sentiment but a weak long-term outlook, with specific signals and risk-reward setups for different trading approaches. The analysis provides entry, target, and stop-loss levels for position trading, momentum, and risk hedging strategies.
Enterprise value to EBIT forward of U.S. Physical Therapy, Inc. – BOATS:USPH
This article displays the enterprise value to EBIT forward data for U.S. Physical Therapy, Inc. (USPH) on the TradingView platform. The content primarily shows navigation elements and company branding related to TradingView and USPH, indicating that detailed financial data is typically presented in this section of the platform.
Enterprise value to EBIT forward of U.S. Physical Therapy, Inc. – NYSE:USPH
This article focuses on the enterprise value to EBIT forward metric for U.S. Physical Therapy, Inc. (NYSE: USPH). It provides a snapshot of the company's financial overview on TradingView, listing its stock exchange and indicating that the market was closed at the time of publication. The content primarily highlights financial data sources and intellectual property rights.
Price to sales forward of U.S. Physical Therapy, Inc. – NYSE:USPH
This article provides the "price to sales forward" value for U.S. Physical Therapy, Inc. (NYSE: USPH). It displays financial data and other information related to the company's stock performance on the New York Stock Exchange. The content is presented within the TradingView platform, focusing on financial metrics for investors.
Price to earnings forward of U.S. Physical Therapy, Inc. – NYSE:USPH
This article provides access to the "Price to earnings forward" financial metric for U.S. Physical Therapy, Inc. (NYSE: USPH) on the TradingView platform. It highlights that the information is made by humans and available in English. The surrounding content primarily consists of navigation, disclaimers, and links to other features of the TradingView website.
U.S. Physical Therapy, Inc. Actuals & Estimates (NYSE:USPH)
This article provides an overview of U.S. Physical Therapy, Inc. (NYSE: USPH) stock, including its current price, market capitalization, volatility, and historical performance. It also details financial estimates, actual earnings, revenue, and dividend information, alongside analysts' future price forecasts. The company's next earnings report is scheduled for July 30, 2026.
Form 4 US Physical Therapy Inc For: 22 June By Investing.com
This article from Investing.com announces the Form 4 filing for US Physical Therapy Inc. corresponding to June 22. It is a brief, content-light report primarily serving as an alert for the regulatory filing, with no additional details provided within the article itself. The article does, however, include stock performance data for various indices and commodities.
US Physical Therapy (NYSE: USPH) interim CFO surrenders shares for tax withholding
US Physical Therapy's (NYSE: USPH) interim CFO, Jason Travis, surrendered 40 shares of common stock valued at $62.24 per share to cover tax withholding obligations associated with the vesting of restricted stock. This transaction was a tax-withholding disposition, not a discretionary sale, and is a routine administration of his equity compensation. Following this, Travis directly holds 3,893 shares, which includes 3,596 restricted shares that will vest through 2030 contingent on his continued service.
USPH (USPH) COO surrenders shares to cover taxes on vesting awards
U.S. Physical Therapy COO Graham D. Reeve reported a share disposition of 762 common shares at $62.24 per share to cover tax withholding obligations from vesting equity awards. After this transaction, Reeve directly holds 29,316 shares, including 19,436 restricted shares that will vest in tranches between August 2026 and March 2030, contingent on his continued employment. The transaction is categorized as a routine tax-related event, not an open-market sale, and is considered neutral in sentiment.
Form 4 US Physical Therapy Inc For: 22 June By Investing.com
This article reports on a Form 4 filing for US Physical Therapy Inc. for June 22. It lists USPH's current stock performance, showing a -1.28% change. The article also provides a general overview of various market indices, commodities, and other stock performance data.
US Physical Therapy Inc (USPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a detailed technical analysis of US Physical Therapy Inc (USPH), focusing on its support and resistance levels, various technical indicators, and moving averages. It highlights the stock's current price momentum, suggesting suitability for range-bound swing trading, and offers a summary of buy, sell, and neutral signals from different indicators. The analysis also includes FAQs explaining technical ratings and moving averages, and current signals for USPH.
U.S. Physical Therapy (USPH) Stock Could Be 32.4% Undervalued After Profit Growth
U.S. Physical Therapy (USPH) recently reported strong profit growth of 115.29% year-over-year, alongside 7.89% revenue growth, suggesting the stock might be undervalued by 32.4% with a fair value of $93.67. This valuation is driven by strategic cost efficiency initiatives and expected margin expansion. However, the stock's high P/E ratio of 125.7x compared to the industry average raises questions about whether the current price truly reflects future growth, with risks including reimbursement pressure and labor shortages.
Precision Trading with U.s. Physical Therapy Inc. (USPH) Risk Zones
This article provides a detailed analysis of U.s. Physical Therapy Inc. (USPH) through the lens of AI-generated trading strategies. It highlights a strong risk-reward setup, divergent sentiment across time horizons, and suggests specific entry points, targets, and stop losses for position trading, momentum breakout, and risk hedging strategies, emphasizing risk management.
Precision Trading with U.s. Physical Therapy Inc. (USPH) Risk Zones
This article provides a detailed analysis of U.s. Physical Therapy Inc. (USPH) using AI models, highlighting current sentiment, support/resistance levels, and risk-reward setups. It outlines three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along with multi-timeframe signal analysis. The report emphasizes the exceptional 52.6:1 risk-reward setup for a potential 15.3% gain.
US Physical Therapy Inc (USPH) Financial Health: Profitability & Balance Sheet Analysis
US Physical Therapy Inc (USPH) has a stable financial score of 8.14, ranking 27th out of 76 in its industry, indicating high operating efficiency. The company reported significant year-over-year growth in its latest quarterly revenue (7.89%) and net profit (115.29%). Despite these positive indicators, specific financial data for cash and cash equivalents, total assets, liabilities, free cash flow, and other detailed metrics have not been disclosed yet.
U.S. Physical Therapy (USPH) Stock Valuation Gap As Earnings Multiple Clashes With Undervaluation Case
U.S. Physical Therapy (USPH) stock has recently seen a gain of 9.0% over the past month but a decline of 14.7% over the last three months, trading at $65.56. While a popular narrative suggests the stock is 30% undervalued with a fair value of $93.67 due to strategic cost efficiencies and growth initiatives, its high P/E ratio of 130x significantly contrasts with the healthcare industry average of 23.1x and a fair ratio of 39.6x. This disparity creates a valuation gap, prompting investors to consider whether the market is already pricing in future growth or if the stock is genuinely undervalued.
USPH: Hospital Alliances And Medicare Pricing Will Support Future Margin Upside
Analysts have slightly lowered their price target for U.S. Physical Therapy (USPH) to $90 from $103 due to revised profitability expectations and a higher projected net debt after a mixed Q1 report. Despite this, the model's fair value estimate remains at $93.67 per share, and the company completed a share repurchase of 81,322 shares for $5.57 million, providing insight into capital allocation. The adjusted valuation model incorporates minor changes in discount rate, revenue growth, net profit margin, and future P/E, indicating continued undervaluation at 30.0% below the intrinsic discount.
U.S. Physical Therapy (NYSE:USPH) Stock Price
U.S. Physical Therapy (USPH) is trading at $72.35, which is 22.8% undervalued compared to its fair value of $93.67. The company recently acquired a twelve-clinic practice, expanding its presence to 45 states, and analysts have updated their fair value based on factors like hospital alliances and Medicare pricing. Despite recent profit growth, the stock has seen a decline in total shareholder return over the past one and five years.
U.S. Physical Therapy Stock (US9175021020): Insider buying as shares trade near 52-week low
A director at U.S. Physical Therapy recently purchased shares worth nearly $49,000, signaling insider confidence as the stock trades close to its 52-week low of $58.19. This insider buying provides a notable data point for investors, especially since analysts are maintaining their price targets on the healthcare services group. The purchase suggests a belief in the company's fundamentals and long-term prospects despite current share price weakness.
Peter Francis Minan Acquires 492 Shares of U.S. Physical Therapy (NYSE:USPH) Stock
U.S. Physical Therapy (NYSE:USPH) director Peter Francis Minan recently acquired shares in two separate transactions: 492 shares on June 8th at $63.14 and 288 shares on June 9th at $61.50, increasing his position by 20.24%. Despite these insider purchases, the company's stock experienced a 1.8% gain but remains below key moving averages, and recently missed EPS and revenue estimates, reporting $0.46 EPS for the quarter. The company announced a quarterly dividend of $0.46 per share, and analysts currently rate the stock as a "Moderate Buy" with an average target price of $97.50.
U.S. physical therapy director Peter Minan acquires $48,776 in stock By Investing.com
Peter Francis Minan, a director at U S Physical Therapy Inc. (NASDAQ:USPH), recently acquired 780 shares of the company's common stock for a total of $48,776. These purchases occurred on June 8 and June 9, 2026, at prices between $61.50 and $63.14 per share. Following these transactions, Minan now directly holds 3,211 shares, including restricted stock that vests over time, amidst analysts' price targets suggesting potential upside for USPH, which is trading near its 52-week low.
Hodges Capital Management Inc. Acquires Shares of 35,105 U.S. Physical Therapy, Inc. $USPH
Hodges Capital Management Inc. initiated a new position in U.S. Physical Therapy, acquiring 35,105 shares valued at approximately $2.74 million. Additionally, company director Peter Francis Minan purchased 492 shares, increasing his stake by 20%. This activity occurs despite U.S. Physical Therapy reporting weaker-than-expected quarterly earnings and revenue, though analysts still hold a "Moderate Buy" rating with a $97.50 price target.
US Physical Therapy (USPH) director adds 780 shares in open-market buys
U.S. Physical Therapy director Peter Francis Minan purchased a total of 780 shares of company stock in the open market across two transactions on June 8 and June 9, 2026. These purchases, totaling approximately $48,777, increased his direct holdings to 3,211 common shares, which includes 2,306 shares of restricted stock vesting over the next year. The transactions signal a positive sentiment towards the company from an insider.
U.S. physical therapy director Peter Minan acquires $48,776 in stock
Peter Minan, a director at U S Physical Therapy Inc. (NASDAQ:USPH), recently purchased $48,776 worth of company stock through two transactions. These acquisitions bring his direct holdings to 3,211 shares, including restricted stock that will vest in installments between August 2026 and March 2027. The purchases occurred while USPH stock was near its 52-week low, and analysts maintain price targets suggesting significant potential upside.
U.S. physical therapy director Peter Minan acquires $48,776 in stock
Peter Francis Minan, a director at U S Physical Therapy Inc. (NASDAQ:USPH), recently acquired shares totaling $48,776 in the company, purchasing 780 shares over two days. These acquisitions come as USPH trades near its 52-week low, with analysts maintaining price targets significantly higher than current levels. The company also recently reported first-quarter 2026 earnings below expectations and shareholders approved all proposals at their annual meeting.
Technical Reactions to USPH Trends in Macro Strategies - Stock Traders Daily
This article from Stock Traders Daily provides a technical analysis of U.s. Physical Therapy Inc. (NASDAQ: USPH), noting weak near-term sentiment and the absence of clear price positioning signals. It outlines institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis to guide investors on potential movements and risk management. The report highlights elevated downside risk due to a lack of additional long-term support signals.
USPH Technical Analysis & Stock Price Forecast
This article provides a technical analysis and stock price forecast for US Physical Therapy Inc (USPH) as of June 5, 2026. It indicates an overall technical consensus of "Buy" for USPH, based on a combination of moving averages and oscillators, with 7 buy signals and 5 sell signals. Key financial indicators like RSI, MACD, and various moving averages are detailed, along with crucial support and resistance levels.
USPH - U.S. Physical Therapy Inc Stock Price and Quote
This page provides a detailed overview of U.S. Physical Therapy Inc (USPH) stock, including its latest closing price, financial metrics, and recent news. It covers key data points such as market cap, P/E ratio, dividend information, and sales performance. The article also lists recent analyst ratings and insider transactions, offering a comprehensive financial snapshot of the company.
USPH: Hospital Alliances And Medicare Pricing Will Drive Future Margin Recovery
Analysts have adjusted their price target for U.S. Physical Therapy (USPH) down to roughly $94 from $107, reflecting lower P/E assumptions, softer profitability expectations, and higher net debt. Despite this, some analysts are optimistic that hospital alliances and improved Medicare rates could drive future margin recovery and organic growth. The company's fair value has decreased by 12% to $93.67, with a revised future P/E cut sharply from 37.13x to 17.31x, signaling a more conservative earnings multiple.
Director at U S Physical Therapy (NYSE: USPH) granted 2,306 shares
U.S. Physical Therapy (NYSE: USPH) director Bernard A. Harris Jr. was granted 2,306 shares of common stock as a restricted stock award. The shares were granted at $0.00 per share and increased his direct holdings to 20,914 shares. These restricted shares will vest in stages on August 20, 2026, November 20, 2026, and March 6, 2027, contingent on his continued service as a director.
US Physical Therapy (NYSE: USPH) director receives 2,306 restricted stock shares
U.S. Physical Therapy (NYSE: USPH) director Peter Francis Minan was granted 2,306 restricted stock shares as a stock award with a corrected transaction price of $0.00 per share. These shares are part of the company's Amended and Restated 2003 Stock Incentive Plan and will vest in tranches between August 2026 and March 2027, provided Minan remains a director. After this grant, Minan directly holds 2,431 shares.
U.S. Physical Therapy (USPH) director receives 2,306-share restricted stock grant
U.S. Physical Therapy director Regg E. Swanson was granted 2,306 restricted shares of common stock at a price of $0.00 per share, correcting a prior report. These shares will vest in tranches between August 2026 and March 2027, provided he remains a director. Following this award, Swanson holds 15,492 shares directly and 7,596 shares indirectly through his revocable trust.
Director at U.S. Physical Therapy (NYSE: USPH) receives 2,306 restricted shares
U.S. Physical Therapy (NYSE: USPH) director Anne Motsenbocker was granted 2,306 restricted shares of common stock on May 19, 2026, as part of the company’s Amended and Restated 2003 Stock Incentive Plan. The shares were granted at $0.00 and will vest in tranches, bringing her direct holdings to 9,812 shares. This Form 4/A filing corrects an earlier report regarding the transaction price.
U.S. Physical Therapy (NYSE: USPH) director receives 2,306-share stock grant
U.S. Physical Therapy director Kathleen A. Gilmartin received a grant of 2,306 restricted shares of Common Stock as compensation. These shares, granted at $0.00 per share, were part of the Company Amended and Restated 2003 Stock Incentive Plan and increase her direct holdings to 27,092 shares. The restricted shares will vest in tranches on specified future dates, provided she continues her role as a director.
USPH Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial analysis of US Physical Therapy Inc (USPH), detailing its revenue breakdown, profitability margins, and a comparison with competitors like AZTA and OPK. The company primarily generates revenue from physical therapy operations, accounting for 85.3% of its sales. Key financial metrics such as gross margin, operating margin, net margin, and Return on Equity are presented to illustrate USPH's financial health and efficiency.
William Blair Investment Management LLC Has $28.95 Million Stake in U.S. Physical Therapy, Inc. $USPH
William Blair Investment Management LLC increased its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 7.2% in the fourth quarter, reaching a total value of approximately $28.95 million. Despite this increased institutional interest, the company reported mixed quarterly results with revenue up 7.9% year-over-year but adjusted EPS missing analyst expectations. Analysts currently rate USPH as a "Moderate Buy" with a consensus price target of $97.50, and the company has declared a quarterly dividend of $0.46 per share.
U.S. Physical Therapy (NYSE:USPH) Stock Forecast & Analyst Predictions
U.S. Physical Therapy (NYSE:USPH) is projected to grow earnings by 47.5% and revenue by 7.3% annually. Despite recent EPS estimate revisions and price target adjustments, analysts note potential margin recovery from hospital alliances and Medicare pricing. The company has seen increased revenue from acquisitions and hospital partnerships but experienced a Q1 2026 net loss due to higher costs and weather disruptions.
Director at U S Physical Therapy (NYSE: USPH) receives stock grant
U S Physical Therapy director Anne Motsenbocker was granted 2,306 restricted shares of common stock at $61.61 per share as equity compensation, increasing her direct holdings to 9,812 shares. The restricted shares will vest in three tranches between August 2026 and March 2027, provided she remains a director. This insider transaction was reported via a Form 4 filing and is part of the company's 2003 Stock Incentive Plan.
